SlideShare una empresa de Scribd logo
1 de 33
 Bones are rigid organs that form part of
the endoskeleton of vertebrates.

Functions:
 Movement


 Support


 Protect various organs of the body
 Production of blood cells


 Store minerals



Disorders of bone:

 Bone fracture
 Osteomyelitis
 Osteoarthritis
 Osteoporosis
 Osteoporosis is a condition
characterized by a decrease in the density
of bone, decreasing its strength and
resulting in fragile bones.

 It leads to abnormally porous bone that
is compressible, like a sponge.

 Normal bone is composed of protein,
collagen, and calcium, all of which give
bone its strength.
 This disorder of the skeleton weakens the
bone and results in the frequent fractures in
the bone.

 The spine, hips, ribs, and wrists are common
areas of bone fractures from osteoporosis.
 Fractures - over 1.5 million annually caused by
osteoporosis in the USA.


 Vertebrae fracture - approximately 700,000
vertebral (spinal) fractures annually in the USA.


 Hip fracture - about 300,000 hip fractures
due to osteoporosis annually in the USA.


 Wrist fracture - about 250,000 wrist
fractures in the USA.
Primary osteoporosis:

 The condition is caused by age-related
bone loss.

 Usually in people after the age of 70.
Secondary osteoporosis:

 The loss of bone mass is caused by
lifestyle factors, diseases or medications.

Causes:
 Hypogonadism
 alcohol abuse
hypercalciurea
 immobilization
• At the top is the
  normal Bone



• Effected by
  osteopenia showing
  lack of calcium



• Severe case of
  osteoporosis
   Thin and small body frame

 Family history of osteoporosis


 Smoking
 Low testosterone levels in men
(hypogonadism)

 Chemotherapy

 Chronic inflammation, due to chronic
diseases such as rheumatoid arthritis or
liver diseases

 Hyperthyroidism
 Vitamin D deficiency
 Excessive alcohol consumption




   Diet low in calcium

 Malabsorption
 Fracture
 Swelling


 Joint pain


 Disfigurement


 Debilitation


 Kyphosis (is a common condition of a
curvature of the upper back.)
 A routine X-ray can reveal osteoporosis of the
bone because the bones appear much thinner and
lighter than normal bones.

 Bone mineral density test that can measure the
strength of your bone.

 Often blood tests are used to measure
calcium, phosphorus, vitamin D, testosterone, and
thyroid and kidney function.

 Ultrasound .
 Lifestyle changes


 curtailing excessive alcohol intake


 exercising regularly


consuming a balanced diet with
adequate calcium and vitamin D.
 BIOPHOSPHONATES                 :
      GENERIC NAME         TRADE NAME

  • Alendronate       • Fosamax


  • Ibandronate
                      • Boniva


  • Zoledronic acid   • Reclast
 CALCITONIN:

        GENERIC NAME         TRADE NAME
    • Calcitonin        • Cibacalcin




 RALOXIFENE:
         GENERIC NAME         TRADE NAME

     • Raloxifene        • Evista
Biophosphonates:
   Alendronate (Fosamax)

Ibandronate (Boniva)


Zoledronic acid (Reclast)
MODE OF ACTION
 This class of medicines slow the rate of bone
    thinning and can lead to increased bone
                    density.
  Bisphosphonates’ mechanisms of action all
   stem from their structures' similarity to
pyrophosphate. A bisphosphonate group mimics
pyrophosphate's structure, thereby inhibiting
       activation of enzymes that utilize
                 pyrophosphate.
PHARMACOKINETICS

Of the bisphosphonate that is resorbed (from
 oral preparation) or infused (for intravenous
 drugs), about 50% is excreted unchanged by
  the kidney. The remainder has a very high
    affinity for bone tissue, and is rapidly
       adsorbed onto the bone surface.
Side effects:

 Heartburn, abdominal pain, and irritation
of the esophagus.

Headache and pain in muscles and joints.
Calcitonin
 Cibacalcin
                MODE OF ACTION

It helps to regulate calcium levels in your body and is
          part of the bone-building process.
  Calcitonin is potent inhibitor of osteoclastic bone
                      resorption.
 Calcitonin inhibits bone resorption and slows down
                   rate of bone loss.
Side effects:
 Runny nose or nasal discomfort.
 Nausea.
 Skin redness (flushing).
Raloxifene (Evista)

            MODE OF ACTION
 Evista (raloxifene) reduces the amount of
calcium lost from bones. It helps to prevent
bone loss and to increase normal healthy bone
formation in patients with osteoporosis.

  Side effects
• Swelling.
• Warmth.
• Pain or tenderness.
• Redness.
DOSAGE
       DRUGS                     DOSE
 Boniva (Ibandronate)    white, oblong, 2.5 mg
                         film-coated tablet


 Cibacalcin              100-200ul in nasal
(Calcitonin)             spray form, one puff
                         per day


                          1 tablet (60 mg)
Evista (Raloxifene)     orally once a day
Physical therapy:

 Help you build bone strength and
improve your posture.

 Balance and muscle strength.
 Eat your veggies and fruit


 Get some daily sunshine for
vitamin D
REFERENCES
 Drugs.com
 Medicine.net
 Medscape education.com
Science daily.com
Osteoporosis

Más contenido relacionado

La actualidad más candente

Osteoporosis.ppt
Osteoporosis.pptOsteoporosis.ppt
Osteoporosis.ppt
Shama
 

La actualidad más candente (20)

osteoporosis
osteoporosisosteoporosis
osteoporosis
 
Osteoarthritis
OsteoarthritisOsteoarthritis
Osteoarthritis
 
Osteoporosis-pathogenesis, diagnosis, management and prevention
Osteoporosis-pathogenesis, diagnosis, management and preventionOsteoporosis-pathogenesis, diagnosis, management and prevention
Osteoporosis-pathogenesis, diagnosis, management and prevention
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Osteoporosis - Therapeutics
Osteoporosis - TherapeuticsOsteoporosis - Therapeutics
Osteoporosis - Therapeutics
 
Osteoporosis prevention and management
Osteoporosis prevention and managementOsteoporosis prevention and management
Osteoporosis prevention and management
 
Osteoporosis my ppt
Osteoporosis my pptOsteoporosis my ppt
Osteoporosis my ppt
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Osteoporosis.ppt
Osteoporosis.pptOsteoporosis.ppt
Osteoporosis.ppt
 
Osteoporosis Seminar
Osteoporosis Seminar Osteoporosis Seminar
Osteoporosis Seminar
 
Osteoporosis a
Osteoporosis aOsteoporosis a
Osteoporosis a
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Osteoporosis - diagnosis , management 2016
Osteoporosis - diagnosis , management 2016Osteoporosis - diagnosis , management 2016
Osteoporosis - diagnosis , management 2016
 
Webinar on Osteoporosis by Hinduja Hospital
Webinar on Osteoporosis by Hinduja HospitalWebinar on Osteoporosis by Hinduja Hospital
Webinar on Osteoporosis by Hinduja Hospital
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Osteoporosis - Pharmacotherapy
Osteoporosis - Pharmacotherapy Osteoporosis - Pharmacotherapy
Osteoporosis - Pharmacotherapy
 

Destacado

Endocarditis infecciosa version2
Endocarditis infecciosa version2Endocarditis infecciosa version2
Endocarditis infecciosa version2
Adelina M-a
 

Destacado (15)

Caso antomoclinico enfermedad de paget
Caso antomoclinico enfermedad de pagetCaso antomoclinico enfermedad de paget
Caso antomoclinico enfermedad de paget
 
Vitamins a b c d
Vitamins a b c dVitamins a b c d
Vitamins a b c d
 
Enfermedades oseas
Enfermedades oseasEnfermedades oseas
Enfermedades oseas
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Osteomalacia and rickets
Osteomalacia and ricketsOsteomalacia and rickets
Osteomalacia and rickets
 
Endocarditis fisiopatologia
Endocarditis fisiopatologiaEndocarditis fisiopatologia
Endocarditis fisiopatologia
 
Endocarditis infecciosa version2
Endocarditis infecciosa version2Endocarditis infecciosa version2
Endocarditis infecciosa version2
 
Endocarditis
EndocarditisEndocarditis
Endocarditis
 
Endocarditis infecciosa
Endocarditis infecciosaEndocarditis infecciosa
Endocarditis infecciosa
 
Endocarditis infecciosa: guías AHA 2014
Endocarditis infecciosa: guías AHA 2014Endocarditis infecciosa: guías AHA 2014
Endocarditis infecciosa: guías AHA 2014
 
Endocarditis Infecciosa
Endocarditis  InfecciosaEndocarditis  Infecciosa
Endocarditis Infecciosa
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 

Similar a Osteoporosis

Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
DhieMhie
 
Seminar on pharmacotherapy of osteoporosis copy
Seminar on pharmacotherapy of osteoporosis   copySeminar on pharmacotherapy of osteoporosis   copy
Seminar on pharmacotherapy of osteoporosis copy
dip4pharma
 
Treatment&prevention
Treatment&preventionTreatment&prevention
Treatment&prevention
um5ashm
 
Treatment&prevention.
Treatment&prevention.Treatment&prevention.
Treatment&prevention.
um5ashm
 
Basic science of bone
Basic science of boneBasic science of bone
Basic science of bone
Amanj Gardi
 

Similar a Osteoporosis (20)

core_course_lecture_-_osteoprosis_2010.ppt
core_course_lecture_-_osteoprosis_2010.pptcore_course_lecture_-_osteoprosis_2010.ppt
core_course_lecture_-_osteoprosis_2010.ppt
 
Osteomalacia osteoporosis
Osteomalacia osteoporosisOsteomalacia osteoporosis
Osteomalacia osteoporosis
 
Osteoporosis Prevention And Management
Osteoporosis Prevention And ManagementOsteoporosis Prevention And Management
Osteoporosis Prevention And Management
 
METABOLIC BONE DISORDER seminar presentation pptx
METABOLIC BONE DISORDER  seminar presentation pptxMETABOLIC BONE DISORDER  seminar presentation pptx
METABOLIC BONE DISORDER seminar presentation pptx
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Seminar on pharmacotherapy of osteoporosis copy
Seminar on pharmacotherapy of osteoporosis   copySeminar on pharmacotherapy of osteoporosis   copy
Seminar on pharmacotherapy of osteoporosis copy
 
Calsi soya ppt
Calsi soya pptCalsi soya ppt
Calsi soya ppt
 
Osteoporosis ppt
Osteoporosis pptOsteoporosis ppt
Osteoporosis ppt
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
0 steoporosis
0 steoporosis0 steoporosis
0 steoporosis
 
0steoporosis
0steoporosis0steoporosis
0steoporosis
 
Treatment&prevention
Treatment&preventionTreatment&prevention
Treatment&prevention
 
Treatment&prevention.
Treatment&prevention.Treatment&prevention.
Treatment&prevention.
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
Strong Bones Stronger Women
Strong Bones Stronger WomenStrong Bones Stronger Women
Strong Bones Stronger Women
 
Osteoporosis
OsteoporosisOsteoporosis
Osteoporosis
 
osteoporosis
osteoporosisosteoporosis
osteoporosis
 
Basic science of bone
Basic science of boneBasic science of bone
Basic science of bone
 
Metabolic bone disease.pptx
Metabolic bone disease.pptxMetabolic bone disease.pptx
Metabolic bone disease.pptx
 
Pharmacotherapy of osteoporosis
Pharmacotherapy of osteoporosisPharmacotherapy of osteoporosis
Pharmacotherapy of osteoporosis
 

Último

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Último (20)

Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 

Osteoporosis

  • 1.
  • 2.  Bones are rigid organs that form part of the endoskeleton of vertebrates. Functions:  Movement  Support  Protect various organs of the body
  • 3.  Production of blood cells  Store minerals Disorders of bone:  Bone fracture  Osteomyelitis  Osteoarthritis  Osteoporosis
  • 4.  Osteoporosis is a condition characterized by a decrease in the density of bone, decreasing its strength and resulting in fragile bones.  It leads to abnormally porous bone that is compressible, like a sponge.  Normal bone is composed of protein, collagen, and calcium, all of which give bone its strength.
  • 5.  This disorder of the skeleton weakens the bone and results in the frequent fractures in the bone.  The spine, hips, ribs, and wrists are common areas of bone fractures from osteoporosis.
  • 6.
  • 7.  Fractures - over 1.5 million annually caused by osteoporosis in the USA.  Vertebrae fracture - approximately 700,000 vertebral (spinal) fractures annually in the USA.  Hip fracture - about 300,000 hip fractures due to osteoporosis annually in the USA.  Wrist fracture - about 250,000 wrist fractures in the USA.
  • 8. Primary osteoporosis:  The condition is caused by age-related bone loss.  Usually in people after the age of 70.
  • 9. Secondary osteoporosis:  The loss of bone mass is caused by lifestyle factors, diseases or medications. Causes:  Hypogonadism  alcohol abuse hypercalciurea  immobilization
  • 10. • At the top is the normal Bone • Effected by osteopenia showing lack of calcium • Severe case of osteoporosis
  • 11. Thin and small body frame  Family history of osteoporosis  Smoking
  • 12.  Low testosterone levels in men (hypogonadism)  Chemotherapy  Chronic inflammation, due to chronic diseases such as rheumatoid arthritis or liver diseases  Hyperthyroidism
  • 13.  Vitamin D deficiency
  • 14.  Excessive alcohol consumption  Diet low in calcium  Malabsorption
  • 16.  Swelling  Joint pain  Disfigurement  Debilitation  Kyphosis (is a common condition of a curvature of the upper back.)
  • 17.  A routine X-ray can reveal osteoporosis of the bone because the bones appear much thinner and lighter than normal bones.  Bone mineral density test that can measure the strength of your bone.  Often blood tests are used to measure calcium, phosphorus, vitamin D, testosterone, and thyroid and kidney function.  Ultrasound .
  • 18.
  • 19.  Lifestyle changes  curtailing excessive alcohol intake  exercising regularly consuming a balanced diet with adequate calcium and vitamin D.
  • 20.  BIOPHOSPHONATES : GENERIC NAME TRADE NAME • Alendronate • Fosamax • Ibandronate • Boniva • Zoledronic acid • Reclast
  • 21.  CALCITONIN: GENERIC NAME TRADE NAME • Calcitonin • Cibacalcin  RALOXIFENE: GENERIC NAME TRADE NAME • Raloxifene • Evista
  • 22. Biophosphonates:  Alendronate (Fosamax) Ibandronate (Boniva) Zoledronic acid (Reclast)
  • 23. MODE OF ACTION This class of medicines slow the rate of bone thinning and can lead to increased bone density. Bisphosphonates’ mechanisms of action all stem from their structures' similarity to pyrophosphate. A bisphosphonate group mimics pyrophosphate's structure, thereby inhibiting activation of enzymes that utilize pyrophosphate.
  • 24. PHARMACOKINETICS Of the bisphosphonate that is resorbed (from oral preparation) or infused (for intravenous drugs), about 50% is excreted unchanged by the kidney. The remainder has a very high affinity for bone tissue, and is rapidly adsorbed onto the bone surface.
  • 25. Side effects:  Heartburn, abdominal pain, and irritation of the esophagus. Headache and pain in muscles and joints.
  • 26. Calcitonin  Cibacalcin MODE OF ACTION It helps to regulate calcium levels in your body and is part of the bone-building process. Calcitonin is potent inhibitor of osteoclastic bone resorption. Calcitonin inhibits bone resorption and slows down rate of bone loss.
  • 27. Side effects:  Runny nose or nasal discomfort.  Nausea.  Skin redness (flushing).
  • 28. Raloxifene (Evista) MODE OF ACTION  Evista (raloxifene) reduces the amount of calcium lost from bones. It helps to prevent bone loss and to increase normal healthy bone formation in patients with osteoporosis.  Side effects • Swelling. • Warmth. • Pain or tenderness. • Redness.
  • 29. DOSAGE DRUGS DOSE  Boniva (Ibandronate)  white, oblong, 2.5 mg film-coated tablet  Cibacalcin  100-200ul in nasal (Calcitonin) spray form, one puff per day  1 tablet (60 mg) Evista (Raloxifene) orally once a day
  • 30. Physical therapy:  Help you build bone strength and improve your posture.  Balance and muscle strength.
  • 31.  Eat your veggies and fruit  Get some daily sunshine for vitamin D
  • 32. REFERENCES  Drugs.com  Medicine.net  Medscape education.com Science daily.com